The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells
Journal of Experimental Medicine · 03.08.2026 · 223 (8)
DOI: 10.1084/jem.20252115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 22.06.2026. Verfasst von Marco Ongaro und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental Oncology UNIL, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Lausanne, Max Cloëtta Foundation, Swiss National Science Foundation.
Abstract (Originalsprache)
T cell exhaustion is a major obstacle to effective immunotherapy in cancer and chronic infection. Here, we identify the transcription factor IRF8 as a tumor-specific regulator of CD8+ T cell exhaustion. IRF8 is strongly expressed in tumor-reactive CD8+ T cells but not during chronic viral infection. Its expression is induced by TCR signaling and can be suppressed by type I IFN (IFN-I). Sustained IFN-I signaling, a hallmark of chronic infection, correlates with reduced chromatin accessibility at the Irf8 locus and progressive repression of Irf8 expression. In tumor-specific CD8+ T cells, IRF8 overexpression enhanced TOX expression while reducing IFNγ, granzyme B, and TNF production. Conversely, Irf8 deficiency diminished exhaustion, restored effector functions, and improved tumor control. Mechanistically, IRF8 directly binds the Tox locus and promotes its transcription. We further show that additional IRF-family transcription factors contribute similarly to the exhausted T cell program, identifying this transcriptional network as a key regulator of tumor-associated T cell dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Fundamental Oncology UNIL, University of Lausanne, Lausanne, Switzerland.
- Ludwig Institute for Cancer Research, University of Lausanne , Lausanne, Switzerland.
- SIB Swiss Institute of Bioinformatics , Lausanne, Switzerland.
ORCID-Profile: Marco Ongaro, Romane Thouenon, Isaac Crespo, Alexandre Dumez, Mélanie Charmoy, Eduardo Roman Camacho, Victoria J Morel, Daniela Cropp, Emma Desponds, Giulio Zanette, Yi-Chuan Wang, Letizia Vergili, Laure Tillé, Inés Di Resta, Marine M Leblond, Jésus Corria Osorio, Ping-Chih Ho, Werner Held, Grégory Verdeil
Förderung
- University of Lausanne
- Max Cloëtta Foundation
- Swiss National Science Foundation
- ISREC Institute
- Swiss Cancer Research Foundation
Zitieren
APA
Ongaro, M., Thouenon, R., Crespo, I., Dumez, A., Charmoy, M., Roman Camacho, E., Morel, V. J., Cropp, D., Desponds, E., Zanette, G., Wang, Y. C., Vergili, L., Tillé, L., Di Resta, I., Leblond, M. M., Corria Osorio, J., Ho, P. C., Held, W., & Verdeil, G. (2026). The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells. Journal of Experimental Medicine, 223(8). https://doi.org/10.1084/jem.20252115
Vancouver
Ongaro M, Thouenon R, Crespo I, Dumez A, Charmoy M, Roman Camacho E, et al. The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells. Journal of Experimental Medicine. 2026;223(8). doi:10.1084/jem.20252115
BibTeX
@article{Ongaro2026,
author = {Ongaro, Marco and Thouenon, Romane and Crespo, Isaac and Dumez, Alexandre and Charmoy, Mélanie and Roman Camacho, Eduardo and Morel, Victoria J and Cropp, Daniela and Desponds, Emma and Zanette, Giulio and Wang, Yi-Chuan and Vergili, Letizia and Tillé, Laure and Di Resta, Inés and Leblond, Marine M and Corria Osorio, Jésus and Ho, Ping-Chih and Held, Werner and Verdeil, Grégory},
title = {The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {8},
doi = {10.1084/jem.20252115}
}
EUVIMED